Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Dec 1;166(6):1758-73.
doi: 10.1084/jem.166.6.1758.

The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens

Affiliations

The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens

C E Rudd et al. J Exp Med. .

Abstract

The T4 (CD4) subset of T lymphocytes has been subdivided into two major subsets, a suppressor/inducer subset (T4+,2H4+) and a helper subset (T4+,2H4-) on the basis of the differential expression of the L-C/T200 (CD45) antigens. The 2H4 antigen itself comprises at least three distinct polypeptides at 125,200, and 220 X 10(3) Mr, of which the 200 and 220 X 10(3) Mr polypeptides constitute the highest Mr isoforms of a pool of five distinct L-C/T200 antigens. The T4+,2H4+ subset expresses at least four of these isoforms at 180, 190, 200, and 220 X 10(3) on the cell surface, while the T4+,2H4- subset expresses only the 180 and 190 X 10(3) Mr forms. Pulse-chase analysis and endoglycosidase treatment revealed that the 125 X 10(3) Mr chain of the 2H4 antigen is nonglycosylated, while the 200 and 220 X 10(3) polypeptides are structurally related and derived by N- and O-linked glycosylation from two nascent subunits at 150 and 160 X 10(3) Mr. The function of the T4+,2H4+ subset could be blocked only by an antibody reactive with the L-C/T200 isoforms enriched with O-linked oligosaccharides at 200 and 220 X 10(3) Mr.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1985 May;41(1):83-93 - PubMed
    1. J Immunol. 1985 Jun;134(6):3762-9 - PubMed
    1. J Exp Med. 1985 Oct 1;162(4):1275-93 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7360-3 - PubMed
    1. J Exp Med. 1986 Apr 1;163(4):774-86 - PubMed

Publication types

MeSH terms